|Bid||3.5200 x 800|
|Ask||3.5400 x 1800|
|Day's Range||3.4000 - 3.6200|
|52 Week Range||1.8200 - 5.1900|
|Beta (5Y Monthly)||2.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.50|
GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that executives from the Company plan to participate in three virtual healthcare conferences in March. More information about the presentations and panel discussions will be available on the Company’s website, under the Investors tab. Details are as follows:
A look at the shareholders of GlycoMimetics, Inc. ( NASDAQ:GLYC ) can tell us which group is most powerful...
GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that it will host a conference call and webcast to report fourth quarter and year-end 2020 financial results on Tuesday, March 2, 2021, at 8:30 a.m. ET.